These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19681122)

  • 1. Oldies but goodies.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):436-7. PubMed ID: 19681122
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
    Lemesle G; De Labriolle A; Bonello L; Syed A; Collins S; Maluenda G; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):428-35. PubMed ID: 19360860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.
    Kini AS; Rafael OC; Sarkar K; Rajdev S; Jakkula M; Mares AM; Kaplish D; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):700-7. PubMed ID: 19496119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ''They can always hurt you more'' bivalirudin and the dynamic balance between bleeding and clotting.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):708-9. PubMed ID: 19856461
    [No Abstract]   [Full Text] [Related]  

  • 5. Regarding changing outcomes and treatment strategies for wire-induced coronary perforations in the era of bivalirudin use. A word of caution concerning the use of bivalirudin during coronary intervention for lesions at high risk for perforation.
    Movahed MR
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):456; author reply 457-8. PubMed ID: 21328688
    [No Abstract]   [Full Text] [Related]  

  • 6. Bivalirudin in acute myocardial infarction: "primum non nocere": the eternal dilemma: balancing risks and benefits in high-risk patients.
    Alfonso F; Paulo M
    JACC Cardiovasc Interv; 2010 Aug; 3(8):803-5. PubMed ID: 20723850
    [No Abstract]   [Full Text] [Related]  

  • 7. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
    Iijima R; Ndrepepa G; Mehilli J; Byrne RA; Schulz S; Neumann FJ; Richardt G; Berger PB; Schömig A; Kastrati A
    Eur Heart J; 2009 Feb; 30(3):290-6. PubMed ID: 19147609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
    JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failed pericardiocentesis for acute cardiac tamponade: two cases associated with bivalirudin administration during PCI.
    Al Shammeri OM; Crowell R; Stewart K; Fort S
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):114-6. PubMed ID: 19626695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side branch jailing: should we worry?
    Belardi JA
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):958-9. PubMed ID: 21108372
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility and safety of transradial approach and bivalirudin treatment in elderly patients undergoing early invasive strategy for ACS: 'The OLDER Research Project' preliminary study.
    Summaria F; Romagnoli E; De Luca L; Mustilli M; Pagnanelli A
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):351-2. PubMed ID: 22476002
    [No Abstract]   [Full Text] [Related]  

  • 13. The changing horizon of acute coronary syndrome.
    de Silva R; Fox KM
    Lancet; 2009 Oct; 374(9696):1125-7. PubMed ID: 19717183
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter by De Servi and Navarese regarding article, "Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial".
    De Servi S; Navarese E
    Circulation; 2010 Sep; 122(12):e461; author reply e462-3. PubMed ID: 20855666
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease.
    Walker CM
    J Endovasc Ther; 2010 Feb; 17(1):37-8. PubMed ID: 20199264
    [No Abstract]   [Full Text] [Related]  

  • 16. Let it be, let it be.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):898. PubMed ID: 19455656
    [No Abstract]   [Full Text] [Related]  

  • 17. Bivalirudin and DES: a PCI strategy that pays.
    Applegate RJ
    J Invasive Cardiol; 2007 Feb; 19(2):69-70. PubMed ID: 17268040
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
    Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
    Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention in nonagenarians: age before beauty?
    Bhatt DL
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):531-2. PubMed ID: 18307234
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
    J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.